Chondromatrix is a tissue engineering solution designed for the repair of articular cartilage defects through the implantation of autologous chondrocytes cultured, adhered to a collagen membrane. This technology enables the restoration of damaged cartilage structure and improves joint functionality in patients with focal knee lesions.
Chondromatrix uses an advanced autologous chondrocyte implantation procedure that promotes the regeneration of cartilage tissue and the recovery of joint function. This therapeutic strategy helps restore the mechanical properties of cartilage, improve shock absorption, and reduce joint pain in patients with cartilage lesions.
The treatment is based on obtaining chondrocytes from healthy cartilage of the patient, which are cultured in vitro and integrated into a collagen membrane that is later implanted into the damaged cartilage area during surgery. This process promotes tissue regeneration and the restoration of joint function.
The implanted chondrocytes facilitate the formation of tissue similar to hyaline cartilage, which presents better structural and mechanical properties than fibrocartilage. This regenerated tissue contributes to improved cartilage durability, greater resistance to compression, and enhanced shock absorption capacity in the treated joint.
Chondromatrix not only promotes the regeneration of articular cartilage, but also contributes to improving mobility, strength, and functionality of the treated joint. According to the technical documentation, the postoperative rehabilitation designed for this treatment enables progressive recovery and a significant reduction in patient pain.
Designed for healthcare professionals specialized in orthopedics and regenerative medicine.
